Immunostimulant therapies are widely used across preventive care, acute care, and chronic disease management owing to their ability to enhance or modulate the body's immune response. These products, ...
This new article publication from Acta Pharmaceutica Sinica B, discusses a transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB ...
Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer ...
Kinimmune Inc. has received US$400,000 in funding from the National Cancer Institute (NCI) at the National Institutes of Health (NIH) for its phase I STTR application to advance the preclinical ...
Kinimmune is developing KIN-102, a first-in-class immunostimulant that persists in treated tumors to minimize systemic side effects. ST. LOUIS--(BUSINESS WIRE)--Kinimmune, Inc., a clinical-stage ...
IRVING, Texas, Jan. 17 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc., (Nasdaq: CARN) today announced they have signed a term sheet with Veterinary Products ...
US Department of Agriculture authorizes first cytosine-phosphate-guanine (CpG) motif-based immunostimulant shown to effectively reduce Bovine Respiratory Disease (BRD) associated mortality and lung ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results